Jan Maarten Vrolijk

1.8k total citations
21 papers, 488 citations indexed

About

Jan Maarten Vrolijk is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jan Maarten Vrolijk has authored 21 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Jan Maarten Vrolijk's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Jan Maarten Vrolijk is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Jan Maarten Vrolijk collaborates with scholars based in Netherlands, Germany and United States. Jan Maarten Vrolijk's co-authors include Solko W. Schalm, Bettina E. Hansen, Bart L. Haagmans, Artur Kaul, Ralf Bartenschlager, Volker Lohmann, Joost P.H. Drenth, Bart van Hoek, Gerd Bouma and Tom J.G. Gevers and has published in prestigious journals such as The Journal of Infectious Diseases, Gastrointestinal Endoscopy and British Journal of Dermatology.

In The Last Decade

Jan Maarten Vrolijk

21 papers receiving 465 citations

Peers

Countries citing papers authored by Jan Maarten Vrolijk

Since Specialization

Citations

This map shows the geographic impact of Jan Maarten Vrolijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Maarten Vrolijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Maarten Vrolijk more than expected).

Fields of papers citing papers by Jan Maarten Vrolijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Maarten Vrolijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Maarten Vrolijk. The network helps show where Jan Maarten Vrolijk may publish in the future.

Co-authorship network of co-authors of Jan Maarten Vrolijk

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Maarten Vrolijk. A scholar is included among the top collaborators of Jan Maarten Vrolijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Maarten Vrolijk. Jan Maarten Vrolijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction 2025 ·Endoscopy ·(unknown), Foke van Delft, Erwin-Jan M. van Geenen, Auke Bogte, Robert C. Verdonk, Niels G. Venneman, Jan Maarten Vrolijk, (unknown), Rogier P. Voermans, (unknown), Sjoerd D. Kuiken, Rutger Quispel, (unknown), (unknown), Frank P. Vleggaar, Tanya M. Bisseling, (unknown), Marco J. Bruno, Roy L.J. van Wanrooij, Peter D. Siersema	1
2	Efficacy and Safety of 100 Laparoscopy-Assisted Transgastric Endoscopic Retrograde Cholangiopancreatography Procedures in Patients with Roux-en-Y Gastric Bypass 2020 ·Obesity Surgery ·(unknown), Peter J. Wahab, (unknown), Theo Aufenacker, Bart Witteman, Marcel J. M. Groenen, Jan Maarten Vrolijk	8
3	Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis 2019 ·Clinical Gastroenterology and Hepatology ·Simon Pape, Tom J.G. Gevers, (unknown), (unknown), Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M.J. van Nieuwkerk, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Mária Papp, Felix Stickel, Michael A. Heneghan, Joost P.H. Drenth	45
4	Adverse events related to low dose corticosteroids in autoimmune hepatitis 2019 ·Alimentary Pharmacology & Therapeutics ·Floris F. van den Brand, (unknown), Birgit I. Lissenberg‐Witte, Ynto S. de Boer, Bart van Hoek, Joost P.H. Drenth, Robert C. Verdonk, Jan Maarten Vrolijk, Carin M.J. van Nieuwkerk, Gerd Bouma, (unknown)	38
5	Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands 2018 ·Alimentary Pharmacology & Therapeutics ·Floris F. van den Brand, Carin M.J. van Nieuwkerk, Bart J. Verwer, Ynto S. de Boer, Nanne K.H. de Boer, Chris J. Mulder, Elisabeth Bloemena, C. M. Bakker, Jan Maarten Vrolijk, Joost P.H. Drenth, Adriaan C.I.T.L. Tan, Frank ter Borg, (unknown), (unknown), Akin Inderson, Maarten E. Tushuizen, Gerd Bouma	21
6	Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono‐infection 2018 ·Liver International ·(unknown), Colette Smit, Clemens Richter, Karel J. van Erpecum, B.W.M. Spanier, Elisabeth H. Gisolf, Jan Maarten Vrolijk, Peter D. Siersema, Andy I. M. Hoepelman, Peter Reiss, Joop E. Arends	15
7	Clinical impact of five large‐scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands 2016 ·Liver International ·(unknown), Suzanne van Meer, Jan Maarten Vrolijk, Clemens Richter, Karel J. van Erpecum, Marijke Mostert, Irene Veldhuijzen, Jurriën G.P. Reijnders, (unknown), (unknown), Joost P.H. Drenth, (unknown), (unknown), (unknown), Martijn J. ter Borg, (unknown), Joop E. Arends, M.A.M.T. Verhagen, (unknown), B.W.M. Spanier	13
8	Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. 2014 ·PubMed ·(unknown), Wietske Kievit, Lubbertus C. Baak, C. M. Bakker, Ulrich Beuers, Charles A. Boucher, J.T. Brouwer, David M. Burger, (unknown), Bart van Hoek, A. I. M. Hoepelman, Pieter Honkoop, (unknown), Robert J. de Knegt, Ger H. Koek, Carin M.J. van Nieuwkerk, (unknown), (unknown), Jan Maarten Vrolijk, Joost P.H. Drenth	13
9	Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin 2014 ·Annals of Hepatology ·(unknown), Matthijs van Luin, Caroline Solas, David M. Burger, Jan Maarten Vrolijk	15
10	Cytotoxic T Lymphocyte Antigen–4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis 2013 ·Liver International ·Nicole M. F. van Gerven, Ynto S. de Boer, Antonie Zwiers, Bart van Hoek, Karel J. van Erpecum, Ulrich Beuers, Henk R. van Buuren, Joost P.H. Drenth, Jannie W. den Ouden, Robert C. Verdonk, Ger H. Koek, Johannes T. Brouwer, Maureen M. J. Guichelaar, Jan Maarten Vrolijk, Georg Kraal, Chris J. Mulder, Carin M.J. van Nieuwkerk, Gerd Bouma, (unknown)	11
11	A giant antral ulceration evoked by a rare cause of single-vessel chronic GI ischemia 2010 ·Gastrointestinal Endoscopy ·Jan Maarten Vrolijk, Desirée van Noord, Hence J.M. Verhagen, Peter M. T. Pattynama, Peter Mensink	2
12	No beneficial effects of amantadine in treatment of chronic hepatitis C patients 2009 ·Digestive and Liver Disease ·(unknown), Peter Schaar, Ger H. Koek, Richard A. de Vries, (unknown), Bart van Hoek, Joost P.H. Drenth, Jan Maarten Vrolijk, Rob J. Lieverse, (unknown), A van der Sluys Veer, Peter D. Siersema, M.E.I. Schipper, Karel J. van Erpecum, Greet J. Boland	16
13	Complications of Endoscopic Treatment of Zenker Diverticula 2008 ·Gastrointestinal Endoscopy ·Jan Maarten Vrolijk, Jelle Haringsma, Ernst J. Kuipers	2
14	γ‐Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon‐α‐2b in chronic hepatitis C non‐responders 2007 ·Liver International ·Jean‐François Bergmann, Jan Maarten Vrolijk, Peter van der Schaar, (unknown), Bart van Hoek, A van der Sluys Veer, Richard A. de Vries, Elke Verhey, Bettina E. Hansen, Johannes T. Brouwer, Harry L.A. Janssen, Solko W. Schalm, Robert J. de Knegt	27
15	The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis 2005 ·BMC Gastroenterology ·(unknown), Durk Fekkes, Jan Maarten Vrolijk, Henk R. van Buuren	25
16	The treatment of hepatitis C: history, presence and future. 2004 ·PubMed ·Jan Maarten Vrolijk, Robert J. de Knegt, Bart J. Veldt, Hans Orlent, Solko W. Schalm	15
17	A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C 2003 ·Journal of Virological Methods ·Jan Maarten Vrolijk, Artur Kaul, Bettina E. Hansen, Volker Lohmann, Bart L. Haagmans, Solko W. Schalm, Ralf Bartenschlager	151
18	Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection 2003 ·British Journal of Dermatology ·M. Willems, Kai Munte, Jan Maarten Vrolijk, Jan C. den Hollander, Michael Böhm, (unknown), Robert A. de Man, J.T. Brouwer	34
19	Pretreatment Intrahepatic CD8⁺Cell Count Correlates with Virological Response to Antiviral Therapy in Chronic Hepatitis C Virus Infection 2003 ·The Journal of Infectious Diseases ·Jan Maarten Vrolijk, Jaap Kwekkeboom, Harry L.A. Janssen, Bettina E. Hansen, Pieter E. Zondervan, Albert D. M. E. Osterhaus, S. W. Schalm, Bart L. Haagmans	14
20	[The treatment of hepatitis C]. 2003 ·PubMed ·Hans Orlent, Jan Maarten Vrolijk, Rob A. de Man, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact